No abstract available
MeSH terms
-
Combined Modality Therapy
-
Dacarbazine / adverse effects*
-
Dacarbazine / therapeutic use
-
Female
-
Hodgkin Disease / chemically induced*
-
Humans
-
Interleukin-2 / adverse effects*
-
Interleukin-2 / therapeutic use
-
Melanoma / drug therapy*
-
Melanoma / secondary
-
Middle Aged
Substances
-
Interleukin-2
-
Dacarbazine